8.76
price up icon5.04%   0.42
after-market アフターアワーズ: 8.76
loading
前日終値:
$8.34
開ける:
$8.38
24時間の取引高:
392.02K
Relative Volume:
0.62
時価総額:
$467.57M
収益:
$27.46M
当期純損益:
$-46.05M
株価収益率:
-9.3191
EPS:
-0.94
ネットキャッシュフロー:
$-33.83M
1週間 パフォーマンス:
+2.34%
1か月 パフォーマンス:
-9.50%
6か月 パフォーマンス:
+100.92%
1年 パフォーマンス:
+28.26%
1日の値動き範囲:
Value
$8.345
$8.80
1週間の範囲:
Value
$8.10
$8.80
52週間の値動き範囲:
Value
$4.20
$9.76

Zevra Therapeutics Inc Stock (ZVRA) Company Profile

Name
名前
Zevra Therapeutics Inc
Name
セクター
Healthcare (1172)
Name
電話
(321) 939-3416
Name
住所
1180 CELEBRATION BOULEVARD, SUITE 103, CELEBRATION
Name
職員
69
Name
Twitter
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
ZVRA's Discussions on Twitter

ZVRA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ZVRA
Zevra Therapeutics Inc
8.76 467.57M 27.46M -46.05M -33.83M -1.29
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
405.76 104.50B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
715.19 78.59B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
620.16 37.08B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
233.62 30.13B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
115.30 27.64B 3.30B -501.07M 1.03B -2.1146

Zevra Therapeutics Inc Stock (ZVRA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-10-07 開始されました Guggenheim Buy
2024-09-24 開始されました JMP Securities Mkt Outperform
2024-09-24 繰り返されました Maxim Group Buy
2024-04-02 繰り返されました Maxim Group Buy
2024-03-12 開始されました William Blair Outperform
2023-03-17 開始されました Maxim Group Buy
すべてを表示

Zevra Therapeutics Inc (ZVRA) 最新ニュース

pulisher
Dec 31, 2024

(ZVRA) Technical Pivots with Risk Controls - Stock Traders Daily

Dec 31, 2024
pulisher
Dec 30, 2024

Sanctuary Advisors LLC Trims Position in Zevra Therapeutics, Inc. (NASDAQ:ZVRA) - MarketBeat

Dec 30, 2024
pulisher
Dec 30, 2024

Sanctuary Advisors LLC Has $194,000 Stock Holdings in Zevra Therapeutics, Inc. (NASDAQ:ZVRA) - Defense World

Dec 30, 2024
pulisher
Dec 30, 2024

State Street Corp Has $5.36 Million Holdings in Zevra Therapeutics, Inc. (NASDAQ:ZVRA) - Defense World

Dec 30, 2024
pulisher
Dec 27, 2024

Analysts Expect Breakeven For Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Before Long - Yahoo Finance

Dec 27, 2024
pulisher
Dec 27, 2024

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

Dec 27, 2024
pulisher
Dec 27, 2024

Analysts Set Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Target Price at $21.00 - MarketBeat

Dec 27, 2024
pulisher
Dec 22, 2024

13,551 Shares in Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Bought by XTX Topco Ltd - Defense World

Dec 22, 2024
pulisher
Dec 20, 2024

(ZVRA) Investment Analysis and Advice - Stock Traders Daily

Dec 20, 2024
pulisher
Dec 19, 2024

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Position Increased by Charles Schwab Investment Management Inc. - Defense World

Dec 19, 2024
pulisher
Dec 17, 2024

Zevra Therapeutics to be Added to Nasdaq Biotechnology Index (Nasdaq: NBI) Effective December 23, 2024 - The Manila Times

Dec 17, 2024
pulisher
Dec 17, 2024

Zevra Therapeutics Secures Coveted Spot in Nasdaq Biotechnology Index Following Transformative Year - StockTitan

Dec 17, 2024
pulisher
Dec 15, 2024

Zevra Therapeutics' SWOT analysis: rare disease drug maker's stock poised for growth - Investing.com

Dec 15, 2024
pulisher
Dec 11, 2024

Fmr LLC Acquires 2,312,384 Shares of Zevra Therapeutics, Inc. (NASDAQ:ZVRA) - MarketBeat

Dec 11, 2024
pulisher
Dec 09, 2024

Zevra Therapeutics Restructures to Focus on Rare Diseases - MSN

Dec 09, 2024
pulisher
Dec 09, 2024

A drug for fewer than 1,000 patients? Awareness and diagnosis are key. - PharmaVoice

Dec 09, 2024
pulisher
Dec 06, 2024

Zevra Therapeutics, Inc. Announces Departure of Executives - Marketscreener.com

Dec 06, 2024
pulisher
Dec 06, 2024

Zevra Therapeutics Announces Organizational Changes - The Manila Times

Dec 06, 2024
pulisher
Dec 06, 2024

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) has caught the attention of institutional investors who hold a sizeable 42% stake - Yahoo Finance

Dec 06, 2024
pulisher
Dec 02, 2024

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Receives $21.00 Consensus Price Target from Brokerages - MarketBeat

Dec 02, 2024
pulisher
Nov 29, 2024

Vestal Point Capital LP Purchases Shares of 525,000 Zevra Therapeutics, Inc. (NASDAQ:ZVRA) - MarketBeat

Nov 29, 2024
pulisher
Nov 26, 2024

179,874 Shares in Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Purchased by Propel Bio Management LLC - MarketBeat

Nov 26, 2024
pulisher
Nov 26, 2024

Zevra Therapeutics to Participate at Upcoming Investor Conferences - The Manila Times

Nov 26, 2024
pulisher
Nov 26, 2024

Zevra Therapeutics CEO to Present at Major Healthcare Investment Conferences | ZVRA Stock News - StockTitan

Nov 26, 2024
pulisher
Nov 23, 2024

Zevra Therapeutics (NASDAQ:ZVRA) Reaches New 52-Week HighShould You Buy? - MarketBeat

Nov 23, 2024
pulisher
Nov 23, 2024

Zevra Therapeutics Launches MIPLYFFA for Niemann-Pick Disease - Yahoo Finance

Nov 23, 2024
pulisher
Nov 22, 2024

ZVRA stock touches 52-week high at $9.6 amid robust growth - Investing.com UK

Nov 22, 2024
pulisher
Nov 22, 2024

Equities Analysts Set Expectations for ZVRA FY2024 Earnings - MarketBeat

Nov 22, 2024
pulisher
Nov 22, 2024

Zevra launches first FDA-approved NPC treatment By Investing.com - Investing.com Australia

Nov 22, 2024
pulisher
Nov 22, 2024

Zevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFA™ (arimoclomol) for Treatment of Niemann-Pick Disease Type C - The Manila Times

Nov 22, 2024
pulisher
Nov 21, 2024

Zevra launches first FDA-approved NPC treatment - Investing.com India

Nov 21, 2024
pulisher
Nov 21, 2024

HC Wainwright Has Negative Forecast for ZVRA FY2028 Earnings - MarketBeat

Nov 21, 2024
pulisher
Nov 20, 2024

Zevra Therapeutics (NASDAQ:ZVRA) Earns "Buy" Rating from HC Wainwright - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

Guggenheim Initiates Coverage of Zevra Therapeutics (ZVRA) with Buy Recommendation - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Zevra Therapeutics (STU:1GDA) Enterprise Value : €424.12 Mil (As of Nov. 20, 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

Zevra Therapeutics Q3 2024 Earnings Preview - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Zevra Therapeutics (ZVRA) Reports Q3 Loss, Lags Revenue Estimates - MSN

Nov 20, 2024
pulisher
Nov 18, 2024

Cantor Fitzgerald Issues Negative Estimate for ZVRA Earnings - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

What is William Blair's Forecast for ZVRA FY2024 Earnings? - MarketBeat

Nov 18, 2024
pulisher
Nov 16, 2024

Analysts Have Made A Financial Statement On Zevra Therapeutics, Inc.'s (NASDAQ:ZVRA) Third-Quarter Report - Yahoo Finance

Nov 16, 2024
pulisher
Nov 15, 2024

Zevra testing beta blocker celiprolol for vEDS in Phase 3 US study - Ehlers-Danlos News

Nov 15, 2024
pulisher
Nov 15, 2024

Simplify Asset Management Inc. Invests $833,000 in Zevra Therapeutics, Inc. (NASDAQ:ZVRA) - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

What is William Blair's Estimate for ZVRA FY2026 Earnings? - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Here's What Analysts Are Forecasting For Zevra Therapeutics, Inc. (NASDAQ:ZVRA) After Its Third-Quarter Results - Simply Wall St

Nov 15, 2024
pulisher
Nov 15, 2024

Roth Capital Forecasts Lower Earnings for Zevra Therapeutics - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Sees Large Decline in Short Interest - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 14, 2024
pulisher
Nov 14, 2024

Earnings call: Zevra Therapeutics reports Q3 financial results - Investing.com

Nov 14, 2024
pulisher
Nov 14, 2024

Canaccord Genuity Group Issues Pessimistic Forecast for Zevra Therapeutics (NASDAQ:ZVRA) Stock Price - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Q4 Earnings Forecast for ZVRA Issued By Roth Capital - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Zevra Therapeutics Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 14, 2024

Zevra Therapeutics Inc (ZVRA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$69.53
price up icon 0.67%
$18.35
price up icon 2.83%
$360.22
price up icon 2.09%
$42.00
price up icon 1.01%
$184.71
price up icon 0.49%
$115.30
price up icon 1.18%
大文字化:     |  ボリューム (24 時間):